Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 38,300
+400 (1.06%)
Apr 10, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 379.23 billion as of April 10, 2026. Its market cap has increased by 92.00% in one year.
Market Cap
379.23B
Enterprise Value
335.65B
Revenue
7.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
38,300.00
Market Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has increased from 291.82B to 379.23B, an increase of 29.95%. That is a compound annual growth rate of 2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 379.23B | -19.10% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medy-Tox | 639.79B |
| Green Cross Holdings | 608.84B |
| SillaJen | 513.15B |
| Genomictree | 412.29B |
| Helixmith | 354.10B |
| BINEX | 344.59B |
| GC Cell | 340.36B |
| HLB Therapeutics | 268.43B |